Oxygenta Pharma Submits 33rd Annual Report for FY26

Oxygenta Pharmaceutical Ltd has submitted its 33rd Annual Report for the Financial Year 2025-26, in compliance with Regulation 34 of SEBI (LODR) Regulations, 2015. The report was dispatched to shareholders on July 30, 2026. The company has also scheduled its 33rd Annual General Meeting (AGM) for August 21, 2026, at 10:30 AM, to be conducted via Video Conference/Other Audio-Visual Means. The AGM agenda includes the adoption of audited financial statements for FY26 and the re-appointment of a director retiring by rotation. A web-link to the Annual Report is available on the company's website for members who have not registered their email addresses.